Ross Feller Casey today filed a lawsuit against the maker and co-promoter of Testim on behalf of the widow of a 45-year-old Virginia man who died of a heart attack while taking the popular testosterone-containing drug.
It is the fourth testosterone lawsuits brought in Philadelphia by Ross Feller Casey in the past two weeks alone.
The suit was filed on behalf of Rosemary Hardwich, whose husband, Stephen T. Hardwich, died of a sudden heart attack on March 9. Stephen Hardwich, of Midlothian, Virginia, began taking Testim in mid-2013, and remained on it until his death. He had no prior history of cardiovascular or cerebrovascular disease.
Among other things, the suit alleges that the defendants’ “defective, inadequate, and unreasonably dangerous warnings and instructions for use, and product design and testing, were a direct and proximate cause of, or increased the risk of harm of, the serious and grievous bodily harm to Stephen Hardwich, including his sudden cardiovascular death.”
Ross Feller Casey has filed three other similar suits in Philadelphia alleging that testosterone-containing drugs cause Alabama man to suffer a stroke, a New Jersey man to have a heart attack, and a Scranton, Pennsylvania man to suffer severe heart damage.
The testosterone lawsuits are believed to be the first four and to date only ones brought in Philadelphia, and among only a very few filed nationwide.
Ross Feller Casey is reviewing many other reports from men across the U.S. who have suffered severe health problems while on AndroGel, Testim, Axiron, AndroDerm, Fortesta, and other so-called “Low T” replacement therapies. The firm expects to bring other “Low T” lawsuits in the coming weeks.
For more information, visit http://www.rossfellercasey.com/practice-areas/lowtlawsuit/